IO Biotech, Inc. IOBT 深 沪
等待开盘 01-30 09:30:00 美东时间
0.3149
+0.005
+1.58%
华盛通- 最 高0.3191
- 今 开0.3057
- 成交量 55.39万股
- 最 低 0.303
- 昨 收 0.31
- 总市值 2265.67万
- 52周最高 2.79
- 市盈率 静 --
- 换手率 0.77%
- 52周最低 0.2053
- 委 比 -38.12%
- 总股本 7194.88万
- 历史最高 17.88
- 量 比 0.02
- 振 幅 5.19%
- 历史最低 0.2053
- 每 手 1
- 风险率 0.46%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 斯伦贝谢、SouthState Bank、西屋制动、特里科银行获多家大行上调目标价；苹果、meta、微软等绩前遭下调目标价
今日重点评级关注：Oppenheimer：维持Pelthos Therapeutics"跑赢大市"评级，目标价从57美元升至60美元；Small Cap Consumer Research：维持Lands' End"买入"评级，目标价从20美元升至45美元
01-27 10:02
Piper Sandler Downgrades IO Biotech to Neutral, Lowers Price Target to $0.5
Piper Sandler analyst Allison Bratzel downgrades IO Biotech (NASDAQ:IOBT) from Overweight to Neutral and lowers the price target from $3 to $0.5.
01-27 02:03
Why High Roller Technologies Shares Are Trading Higher By 30%; Here Are 20 Stocks Moving Premarket
Shares of High Roller Technologies Inc (NYSE:ROLR) rose sharply in pre-market t...
01-22 17:46
BUZZ-U.S. STOCKS ON THE MOVE-Oklo, AMD, Lam Research
BUZZ-U.S. STOCKS ON THE MOVE-Oklo, AMD, Lam Research Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stocks staged a modest recovery on Wednesday after the sharpest equities se
01-22 02:53
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers PAVmed (NASDAQ:PAVM) stock increased by 250.7% to $21.71 during Wednes...
01-22 01:05
IO Biotech to explore strategic alternatives
IO Biotech (IOBT) plans to explore a range of strategic alternatives, including a merger, a business combination, a sale of assets, or a liquidation and dissolution, to maximize stockholder value. The...
01-21 18:37
IO Biotech Considers Strategic Options, Including Possible Sale or Wind-Down
IO Biotech (NASDAQ:IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced that the company intends to explore a range of
01-21 18:32
IO Biotech Announces Exploration of Strategic Alternatives
IO Biotech, a clinical-stage biopharmaceutical company developing cancer vaccines, announced it is exploring strategic alternatives to maximize shareholder value, including mergers, business combinations, asset sales, or liquidation. The company is also evaluating cost-cutting measures such as layoffs. No timetable or agreements have been set, and no updates will be provided unless required by the Board. This press release includes forward-lookin...
01-21 10:30
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Adlai Nortye (NASDAQ:ANL) stock moved upwards by 44.5% to $2.37 during...
2025-12-29 20:05
IO Biotech Announces Publication In Nature Communications Of Long-Term Clinical And Immunological Outcomes From Phase 1/2 Trial MM1636
Findings provide scientific insights into the contributions of IDO1 and PD-L1 vaccination to PD-1 blockade for the treatment of metastatic melanomaFive-year analysis of median progression free survival was 25.5
2025-12-16 05:08
